The "2025 Annual Conference of the World Federation of Chinese Medicine Societies Medical Consortium Working Committee & 'Inheritance, Innovation, Development' Medical Consortium Innovation Symposium" was successfully held in Guangzhou on December 22. The event, hosted by the World Federation of Chinese Medicine Societies Medical Consortium Working Committee and organized by GUSHENGTANG Traditional Chinese Medicine (TCM) Chain Management Group, brought together leaders from the National Administration of Traditional Chinese Medicine, the National Healthcare Security Administration, presidents of top-tier TCM hospitals and universities, as well as nearly 100 renowned experts, scholars, and industry representatives to discuss high-quality development pathways for TCM medical consortia and promote the expansion and allocation of premium healthcare resources.
During the conference, GUSHENGTANG (02273) launched the "Rising Star Scholarship" in collaboration with the Nursing School of Guangzhou University of Chinese Medicine and signed a strategic cooperation agreement with China News of Traditional Chinese Medicine. These initiatives underscore GUSHENGTANG's commitment to deepening industry-education integration and fostering a collaborative ecosystem.
1. **GUSHENGTANG’s Practice: Building a High-Level Medical Consortium Network to Drive Resource Allocation** As an industry leader, GUSHENGTANG’s achievements in medical consortium development took center stage. Wang Shaomin, Partner and Vice President of GUSHENGTANG TCM Group, delivered a keynote report titled "Medical Consortium Collaboration Boosts Grassroots TCM Development," detailing the company’s innovative model.
Since 2025, GUSHENGTANG has added 13 high-level medical consortium partners, including public hospitals such as Wangjing Hospital of China Academy of Chinese Medical Sciences, Bao’an District TCM Hospital of Shenzhen, Hubei Provincial People’s Hospital, and Chengdu University of TCM Second Affiliated Hospital, as well as top academic institutions like Shandong University of TCM and Chengdu University of TCM. To date, GUSHENGTANG has established close collaborations with over 40 public tertiary hospitals and TCM universities, including nine of the top 20 TCM universities in China. The participation of these authoritative institutions reflects strong recognition of GUSHENGTANG’s business model and healthcare service capabilities.
Wang emphasized that GUSHENGTANG’s efficient medical consortium network integrates top-tier experts—such as national TCM masters and renowned scholars—into grassroots communities through regular clinics, remote consultations, mentorship programs, and expert studios. This approach breaks down barriers to accessing premium healthcare, making "elite TCM services accessible to the public" a reality and significantly improving service availability and patient satisfaction.
2. **Talent Development: Launching the "Rising Star Scholarship" to Strengthen Industry-Education Integration** The foundation of TCM’s inheritance and innovation lies in talent cultivation. At the conference, GUSHENGTANG and Guangzhou University of TCM Nursing School signed the "Rising Star Scholarship" agreement, aimed at supporting outstanding nursing students dedicated to TCM careers. This initiative aligns academic education with industry needs, fostering high-caliber talent for TCM and modern medical consortia.
A representative from Guangzhou University of TCM highlighted the "long-standing, multi-dimensional strategic partnership" with GUSHENGTANG, spanning clinical training, joint research, TCM technology promotion, and cultural dissemination.
3. **Ecosystem Collaboration: Partnering with Media to Empower Industry Growth** To amplify TCM culture and share grassroots medical consortium experiences, GUSHENGTANG signed a strategic agreement with China News of Traditional Chinese Medicine. The partnership will leverage combined resources to create high-quality content platforms, enhancing public awareness of TCM health concepts and industry-wide sharing of medical consortium innovations.
The conference featured high-level thematic reports offering insights into medical consortium development. Topics included national healthcare policy guidance, standardized promotion of TCM technologies like "heat-sensitive moxibustion," and the role of medical consortia in hospital advancement.
The event marked a new phase of consensus and collaboration in TCM medical consortium development. As an active contributor, GUSHENGTANG continues to strengthen its unique value in the TCM service system through network expansion, industry-academia partnerships, innovative service models, and open ecosystem collaboration, driving progress toward a "Healthy China."
Comments